{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:02:47Z","timestamp":1792141367439,"version":"4.4.0"},"reference-count":83,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1097\/aog.0b013e3182883a34","type":"journal-article","created":{"date-parts":[[2013,3,22]],"date-time":"2013-03-22T17:32:15Z","timestamp":1363973535000},"page":"829-846","source":"Crossref","is-referenced-by-count":617,"title":["2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors"],"prefix":"10.1097","volume":"121","author":[{"given":"L. Stewart","family":"Massad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Einstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warner K.","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hormuzd A.","family":"Katki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter K.","family":"Kinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Wentzensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herschel W.","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20210126","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":". The 2001 Bethesda System: terminology for reporting results of cervical cytology.","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"R2-19-20210126","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0002-9378(03)00418-6","article-title":"Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance.","volume":"188","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R3-19-20210126","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0002-9378(03)00413-7","article-title":"A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations.","volume":"188","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R4-19-20210126","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.287.16.2120","article-title":"2001 Consensus guidelines for the management of women with cervical cytological abnormalities and cervical cancer precursors: Part 1: Cytological abnormalities.","volume":"287","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"R5-19-20210126","first-page":"154","article-title":"Wilkinson EJ; 2001 ASCCP-sponsored Consensus Workshop. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia.","volume":"7","author":"Wright","year":"2003","journal-title":"J Low Genit Tract Dis"},{"key":"R6-19-20210126","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/LGT.0b013e3181585870","article-title":"Solomon D; 2006 ASCCP-Sponsored Consensus Conference. 2006 consensus guidelines for the management of women with abnormal cervical screening tests.","volume":"11","author":"Wright","year":"2007","journal-title":"J Low Genit Tract Dis"},{"key":"R8-19-20210126","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00128360-200207000-00008","article-title":". ASCCP patient management guidelines: Pap test specimen adequacy and quality indicators.","volume":"6","author":"Davey","year":"2002","journal-title":"J Low Genit Tract Dis"},{"key":"R9-19-20210126","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/LGT.0b013e3181585b9b","article-title":". Cervical cytology specimen adequacy: Updated patient management guidelines.","volume":"12","author":"Davey","year":"2008","journal-title":"J Low Genit Tract Dis"},{"key":"R10-19-20210126","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3322\/caac.21139","article-title":". American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"R11-19-20210126","doi-asserted-by":"crossref","first-page":"880","DOI":"10.7326\/0003-4819-156-12-201206190-00424","article-title":"for the U.S. Preventive Services Task Force. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.","volume":"156","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"key":"R13-19-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/lgt.0b013e31815ea58b","article-title":"Risk assessment to guide the prevention of cervical cancer.","volume":"12","author":"Castle","year":"2008","journal-title":"J Low Genit Tract Dis"},{"key":"R14-19-20210126","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/LGT.0b013e31825c31dd","article-title":"; Members of LAST Project Work Groups. The Lower Anogenital Squamous Terminology Standardization Project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology.","volume":"16","author":"Darragh","year":"2012","journal-title":"J Low Genit Tract Dis"},{"key":"R15-19-20210126","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/00016349709047788","article-title":". Cytobrush and endocervical curettage in the diagnosis of dysplasia and malignancy of the uterine cervix.","volume":"76","author":"Mogensen","year":"1997","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R16-19-20210126","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00404-012-2542-9","article-title":"Diagnostic accuracy of two endocervical sampling method: randomized controlled trial.","volume":"287","author":"Goksedef","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"R18-19-20210126","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ctrv.2006.07.008","article-title":". The up-to-date evidence on colposcopy practice and treatment of cervical intraepithelial neoplasia: the Cochrane colposcopy and cervical cytopathology collaborative group (C5 group) approach.","volume":"32","author":"Kyrgiou","year":"2006","journal-title":"Cancer Treat Rev"},{"key":"R19-19-20210126","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0020-7292(99)00162-9","article-title":"Treatment outcomes for squamous intraepithelial lesions.","volume":"68","author":"Nuovo","year":"2000","journal-title":"Int J Gynaecol Obstet"},{"key":"R20-19-20210126","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ygyno.2006.12.028","article-title":"Cancer free survival after CIN treatment: comparisons of treatment methods and histology.","volume":"105","author":"Kalliala","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R21-19-20210126","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ctrv.2003.07.008","article-title":". The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature.","volume":"30","author":"Paraskevaidis","year":"2004","journal-title":"Cancer Treat Rev"},{"key":"R22-19-20210126","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1471-0528.2009.02115.x","article-title":"Long-term mortality in women treated for cervical intraepithelial neoplasia.","volume":"116","author":"Jakobsson","year":"2009","journal-title":"BJOG"},{"key":"R23-19-20210126","first-page":"113","article-title":"Predictive factors used to justify hysterectomy after loop conization: increasing age and severity of disease.","volume":"18","author":"Kalogirou","year":"1997","journal-title":"Eur J Gynaecol Oncol"},{"key":"R24-19-20210126","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S1470-2045(07)70283-8","article-title":"Incomplete excision of cervical intraepithelial neoplasia and risk of treatment failure: a meta-analysis.","volume":"8","author":"Ghaem-Maghami","year":"2007","journal-title":"Lancet Oncol"},{"key":"R25-19-20210126","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ygyno.2012.01.015","article-title":". High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: a systematic review and meta-analysis.","volume":"125","author":"Kocken","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R26-19-20210126","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1097\/LGT.0b013e3182854253","article-title":". Five-year risk of CIN 3 and cervical cancer among women with HPV testing of ASC-US Pap results.","volume":"17","author":"Katki","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"R27-19-20210126","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/AOG.0b013e3181b052de","article-title":"Loop electrosurgical excision procedure and the risk for preterm birth.","volume":"114","author":"Jakobsson","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R28-19-20210126","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1001\/jama.291.17.2100","article-title":"Treatment for cervical intraepithelial neoplasia and risk of preterm delivery.","volume":"29","author":"Sadler","year":"2004","journal-title":"JAMA"},{"key":"R29-19-20210126","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1471-0528.2011.02944.x","article-title":"The risk of preterm birth following treatment for precancerous changes in the cervix: a systematic review and meta-analysis.","volume":"118","author":"Bruinsma","year":"2011","journal-title":"BJOG"},{"key":"R31-19-20210126","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/AOG.0b013e3181fe777f","article-title":". Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women.","volume":"116","author":"Moscicki","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R32-19-20210126","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/S0140-6736(04)17354-6","article-title":". Regression of low-grade squamous intra-epithelial lesions in young women.","volume":"364","author":"Moscicki","year":"2004","journal-title":"Lancet"},{"key":"R33-19-20210126","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1097\/LGT.0b013e3182854399","article-title":". Five-year risk of CIN 3 to guide the management of women aged 21 to 24 years.","volume":"17","author":"Katki","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"R34-19-20210126","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/LGT.0b013e3181cec411","article-title":"Practice improvement in cervical screening and management (PICSM): symposium on management of cervical abnormalities in adolescents and young women.","volume":"14","author":"Moscicki","year":"2010","journal-title":"J Low Genit Tract Dis"},{"key":"R35-19-20210126","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/AOG.0b013e31826e4609","article-title":"Cervical Cancer Rates Among Young Females in the United States.","volume":"120","author":"Benard","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R36-19-20210126","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/aje\/kwf180","article-title":"Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students.","volume":"157","author":"Winer","year":"2003","journal-title":"Am J Epidemiol"},{"key":"R37-19-20210126","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1001\/jama.285.23.2995","article-title":". Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females.","volume":"285","author":"Moscicki","year":"2001","journal-title":"JAMA"},{"key":"R39-19-20210126","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1089\/jwh.2005.14.650","article-title":". Psychological, behavioral, and interpersonal impact of human papillomavirus and Pap test results.","volume":"14","author":"Kahn","year":"2005","journal-title":"J Womens Health"},{"key":"R40-19-20210126","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1037\/0278-6133.26.2.192","article-title":". Personal Meaning of Human Papillomavirus and Pap Test Results in Adolescent and Young Adult Women.","volume":"26","author":"Kahn","year":"2007","journal-title":"Health Psychol"},{"key":"R41-19-20210126","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/JOM.0b013e3181f12fb0","article-title":". The impact of pre-cancerous cervical lesions on functioning at work and work productivity.","volume":"52","author":"Lerner","year":"2010","journal-title":"J Occup Environ Med"},{"key":"R42-19-20210126","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.5858\/133.12.1912","article-title":". Unsatisfactory reporting rates: 2006 practices of participants in the College of American Pathologists interlaboratory comparison program in gynecologic cytology.","volume":"133","author":"Moriarty","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"R45-19-20210126","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/(SICI)1097-0142(19970625)81:3<139::AID-CNCR2>3.0.CO;2-M","article-title":"Clinicopathologic correlation of the unsatisfactory Papanicolaou smear.","volume":"81","author":"Ransdell","year":"1997","journal-title":"Cancer (Cancer Cytopathol)"},{"key":"R46-19-20210126","doi-asserted-by":"crossref","first-page":"76","DOI":"10.5858\/arpa.2011-0113-OA","article-title":"Causes and relevance of unsatisfactory and satisfactory but limited smears of liquid-based compared with conventional cervical cytology.","volume":"136","author":"Siebers","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"R47-19-20210126","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/LGT.0b013e31818474fd","article-title":"High-risk human papillomavirus DNA test results are useful for disease risk stratification in women with unsatisfactory liquid-based cytology Pap test results.","volume":"13","author":"Zhao","year":"2009","journal-title":"J Lower Genit Tract Dis"},{"key":"R48-19-20210126","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2303.2007.00525.x","article-title":"The effect of lubricant contamination on ThinPrep liquid-based preparations.","volume":"19","author":"Holton","year":"2008","journal-title":"Cytopathology"},{"key":"R49-19-20210126","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1136\/bmj.313.7068.1285","article-title":"Relation between sampling device and detection of abnormality in cervical smears: a meta-analysis of randomized and quasi-randomised studies.","volume":"313","author":"Buntinx","year":"1996","journal-title":"BMJ"},{"key":"R51-19-20210126","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1479-828X.2009.01014.x","article-title":"Outcome in women with no endocervical component on cervical cytology after treatment for high-grade cervical dysplasia.","volume":"49","author":"Huang","year":"2009","journal-title":"Aust N Z J Obstet Gynaec"},{"key":"R52-19-20210126","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1159\/000326428","article-title":"Cervical cytology screening history of women diagnosed with adenocarcinoma in situ of the cervix. A case-control study.","volume":"48","author":"Mitchell","year":"2004","journal-title":"Acta Cytol"},{"key":"R53-19-20210126","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/cncr.9035","article-title":"Longitudinal analysis of histologic high-grade disease after negative cervical cytology according to endocervical status.","volume":"93","author":"Mitchell","year":"2001","journal-title":"Cancer"},{"key":"R54-19-20210126","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1503\/cmaj.101156","article-title":"Management of Papanicolaou test results that lack endocervical cells.","volume":"183","author":"Elumir-Tanner","year":"2011","journal-title":"CMAJ"},{"key":"R55-19-20210126","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ygyno.2007.06.025","article-title":"Human papillomavirus DNA detection in ThinPrep Pap test vials is independent of cytologic sampling of the transformation zone.","volume":"107","author":"Zhao","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R56-19-20210126","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1479-828X.2009.01014.x","article-title":"Outcome in women with no endocervical component on cervical cytology after treatment for high-grade cervical dysplasia.","volume":"49","author":"Huang","year":"2009","journal-title":"Aust NZ J Obstet Gynaecol"},{"key":"R58-19-20210126","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1097\/LGT.0b013e318285437b","article-title":". Five-year risks of CIN 3 and cervical cancer among women who test Pap-negative but are HPV-positive.","volume":"17","author":"Katki","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"R60-19-20210126","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/djn044","article-title":"for the Proyecto Epidemiologico Guanacaste Group. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections.","volume":"100","author":"Rodriguez","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"R61-19-20210126","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1309\/AJCPZ5JY6FCVNMOT","article-title":"High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study.","volume":"135","author":"Stoler","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"R62-19-20210126","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ygyno.2010.04.013","article-title":". Clinical validation of the Cervista HPV HR and 1618 genotyping tests for use in women with ASC-US cytology.","volume":"118","author":"Einstein","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R63-19-20210126","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1158\/1055-9965.EPI-09-1286","article-title":"Comparison of measurements of human papillomavirus persistence for postcolposcopic surveillance for cervical precancerous lesions.","volume":"19","author":"Gage","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R64-19-20210126","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1067\/mob.2003.461","article-title":"Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy.","volume":"188","author":"Cox","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R65-19-20210126","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/LGT.0b013e3181b8b024","article-title":". Lessons from practice: risk of CIN3 or cancer associated with an LSIL or HPV-positive ASC-US screening result in women aged 21-24.","volume":"14","author":"Moore","year":"2010","journal-title":"J Lower Genit Tract Dis"},{"issue":"suppl 3","key":"R66-19-20210126","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.vaccine.2006.05.117","article-title":"Chapter 9: clinical applications of HPV testing: a summary of meta-analyses.","volume":"24","author":"Arbyn","year":"2006","journal-title":"Vaccine"},{"key":"R67-19-20210126","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1097\/LGT.0b013e3182854269","article-title":". Five-year risks of CIN 2 and CIN 3 among women with HPV-positive and HPV-negative LSIL Pap results.","volume":"17","author":"Katki","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"R68-19-20210126","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1097\/LGT.0b013e31828543b1","article-title":". Follow-up testing after colposcopy: five-year risk of CIN 2 after a colposcopic diagnosis of CIN 1 or less.","volume":"17","author":"Katki","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"R69-19-20210126","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1006\/gyno.2001.6323","article-title":"Biopsy correlates of abnormal cervical cytology classified using the Bethesda system.","volume":"82","author":"Massad","year":"2001","journal-title":"Gynecol Oncol"},{"key":"R70-19-20210126","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ygyno.2006.08.056","article-title":"Effective cervical neoplasia detection with a novel optical detection system: a randomized trial.","volume":"104","author":"Alvarez","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R71-19-20210126","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00128360-200304000-00006","article-title":"A see and treat management for high grade squamous intraepithelial lesion Pap smears.","volume":"7","author":"Dunn","year":"2003","journal-title":"J Lower Gen Tract Dis"},{"key":"R72-19-20210126","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1097\/LGT.0b013e3182854282","article-title":". Five-year risk of cervical cancer and CIN3 for HPV-positive and HPV-negative high-grade Pap results.","volume":"17","author":"Katki","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"R73-19-20210126","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ajog.2004.02.065","article-title":". Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of Cervical intraepithelial neoplasia II or worse.","volume":"191","author":"Pretorius","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R74-19-20210126","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.AOG.0000220505.18525.85","article-title":". Number of cervical biopsies and sensitivity of colposcopy.","volume":"108","author":"Gage","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R75-19-20210126","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1067\/mob.2003.456","article-title":"Solomon D; Burke L for the ASCUSLSIL Triage Study (ALTS) Group. Post-colposcopy management strategies for women referred with low-grade squamous intraepithelial lesions of human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective trial.","volume":"188","author":"Guido","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R76-19-20210126","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1309\/HL0B-C7Y6-AC77-ND2U","article-title":". Atypical glandular cells of undetermined significance (AGUS): interobserver reproducibility in cervical smears and corresponding thin-layer preparations.","volume":"117","author":"Lee","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"R77-19-20210126","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.5858\/2004-128-1224-BIARRP","article-title":"Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology.","volume":"128","author":"Davey","year":"2004","journal-title":"Arch Pathol Lab Med"},{"key":"R78-19-20210126","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ygyno.2009.05.019","article-title":"Histologic follow-up results in 662 patients with Pap test findings of atypical glandular cells: results from a large academic womens hospital laboratory employing sensitive screening methods.","volume":"114","author":"Zhao","year":"2009","journal-title":"Gynecol Oncol"},{"key":"R79-19-20210126","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/01.AOG.0000152350.10875.02","article-title":"Dysplasia associated with atypical glandular cells on cervical cytology.","volume":"105","author":"Sharpless","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R80-19-20210126","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/AOG.0b013e3181c799a3","article-title":"Relationship of atypical glandular cell cytology, age and human papillomavirus detection to cervical and endometrial cancer risks.","volume":"115","author":"Castle","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R81-19-20210126","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1309\/LJRD8JGJ7E5ERBUW","article-title":"Reporting endometrial cells in women 70 years and older: assessing the clinical usefulness of Bethesda 2001.","volume":"123","author":"Simsir","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"R82-19-20210126","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/jnci\/djg037","article-title":". Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia.","volume":"95","author":"Schlecht","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"R83-19-20210126","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ygyno.2011.02.018","article-title":". Age distribution of HPV genotypes in cervical intraepithelial neoplasia.","volume":"212","author":"Sideri","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R84-19-20210126","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1158\/1078-0432.CCR-04-2599","article-title":". Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype.","volume":"11","author":"Trimble","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R85-19-20210126","first-page":"917","article-title":"Grading of squamous dysplasia in endocervical curettage specimens: The case for conservative management of mild endocervical dysplasia.","volume":"52","author":"Petersen","year":"2007","journal-title":"J Reprod Med"},{"key":"R87-19-20210126","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00004347-199304000-00018","article-title":"Natural history of cervical intraepithelial neoplasia: A critical review.","volume":"12","author":"Ostor","year":"1993","journal-title":"Intern J Gynecol Pathol"},{"key":"R88-19-20210126","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/91.3.252","article-title":"Natural history of dysplasia of the uterine cervix.","volume":"91","author":"Holowaty","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"R89-19-20210126","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1097\/LGT.0b013e31828543c5","article-title":". Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management.","volume":"17","author":"Katki","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"R90-19-20210126","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/cncr.20877","article-title":"Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival.","volume":"103","author":"Sherman","year":"2005","journal-title":"Cancer"},{"key":"R91-19-20210126","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ygyno.2007.06.021","article-title":"Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix.","volume":"107","author":"Bull-Phelps","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R92-19-20210126","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ygyno.2011.11.039","article-title":". Factors predicting the outcome of conservatively treated adenocarcinoma in situ of the uterine cervix: an analysis of 166 cases.","volume":"124","author":"Costa","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R93-19-20210126","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ygyno.2011.09.006","article-title":"Fertility-sparing treatment in younger women with adenocarcinoma in situ of the cervix.","volume":"124","author":"van Hanegem","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R94-19-20210126","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1006\/gyno.2002.6791","article-title":". Endocervical curettage at conization to predict residual cervical adenocarcinoma in situ.","volume":"87","author":"Lea","year":"2002","journal-title":"Gynecol Oncol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0b013e3182883a34","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T00:33:09Z","timestamp":1644625989000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201304000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0b013e3182883a34","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}